Suitglip-M XR 50/500 Tablet
By Suitglip-M
Rx
10 Tablet XR in a Strip

Composition
Sitagliptin(50mg) + Metformin(500mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
October, 2025
About Suitglip-M XR 50/500 Tablet
SUITGLIP M XR 50/500 TABLET combines the powers of Metformin and Sitagliptin to help manage high blood sugar levels caused by type II diabetes mellitus. This condition can lead to serious complications such as kidney damage and vision problems, as well as increase the risk of heart attacks and strokes. It is essential to maintain a healthy lifestyle with a balanced diet and regular exercise while taking this medication for optimal results.
The dosage of SUITGLIP M XR 50/500 TABLET will be tailored to your individual needs based on your medical condition, blood sugar levels, and other medications you may be taking. It is important to take the tablet consistently at the same time each day, following your doctor's instructions. Taking it with meals can help reduce the likelihood of experiencing an upset stomach.
While using SUITGLIP M XR 50/500 TABLET, it is crucial to be aware of possible side effects such as diarrhea, nausea, vomiting, headache, and sore throat. Additionally, there is a risk of low blood sugar levels (hypoglycemia), especially when used in combination with other diabetes medications like insulin or sulfonylureas. Understanding the signs of hypoglycemia and how to manage it is vital for your safety.
Before starting treatment with SUITGLIP M XR 50/500 TABLET, inform your doctor about any history of kidney, liver, or heart disease, pancreatic issues, or alcohol consumption habits. Pregnant or breastfeeding women should seek medical advice before taking this medication. It is also crucial to disclose all other medications you are currently taking to prevent any potential interactions.
Regular monitoring of kidney function and blood sugar levels will be conducted by your doctor throughout the treatment period to ensure the medication is well-tolerated. Lifestyle changes, including a healthy diet, regular exercise, and alcohol avoidance, are often recommended to complement the effects of SUITGLIP M XR 50/500 TABLET. If you experience any bothersome side effects while taking this medication, consult your doctor for guidance and support.
Benefits
Suitglip-M XR 50/500 Tablet offers several benefits for individuals with Type 2 diabetes mellitus. It is a combination of two medicines that work in tandem to lower blood glucose levels, a key aspect of diabetes management. By effectively controlling blood glucose levels with this medication, the risk of developing serious complications associated with diabetes, such as kidney damage, eye damage, nerve issues, and limb loss, is significantly reduced. Furthermore, maintaining proper control of diabetes can also lower the risk of heart disease and stroke. Consistent use of Suitglip-M XR 50/500 Tablet alongside a balanced diet and regular exercise can contribute to a normal, healthy life. It is crucial to adhere to the prescribed regimen of this medication to safeguard future health outcomes. Overall, Suitglip-M XR 50/500 Tablet provides a comprehensive approach to managing Type 2 diabetes mellitus and reducing the associated risks, allowing individuals to lead a fulfilling and healthy lifestyle.
How to use the Suitglip-M XR 50/500 Tablet
To use Suitglip-M XR 50/500 Tablet effectively, always follow your doctor's advice or carefully read the directions on the label. It is recommended to take Suitglip-M XR 50/500 Tablet with food. Typically, this medication is best taken after meals, but make sure to follow your physician's instructions. Swallow the tablet whole with a full glass of water; do not crush or chew it. Your doctor will determine the correct dosage and duration of treatment based on factors such as your age, weight, and the specific condition being treated. It is important not to discontinue the use of Suitglip-M XR 50/500 Tablet unless instructed to do so by your doctor. By following these guidelines, you can maximize the effectiveness of the medication and ensure proper treatment of your condition.
Uses of Suitglip-M XR 50/500 Tablet
Suitglip-M XR 50/500 Tablet is primarily used for the treatment of Type 2 diabetes mellitus. It is specifically designed to help manage and control this condition. By taking this medication as prescribed, individuals with Type 2 diabetes mellitus can effectively regulate their blood sugar levels and improve their overall health. Suitglip-M XR 50/500 Tablet plays a crucial role in the management of this chronic condition, helping patients lead a healthier and more active life.
What conditions Suitglip-M XR 50/500 Tablet treats?
Suitglip-M XR 50/500 Tablet is used in the treatment of type 2 diabetes mellitus. It combines two medicines that work together to lower blood glucose levels, which is crucial in managing diabetes. By controlling blood sugar levels, the risk of serious complications like kidney damage, eye damage, nerve problems, and limb loss is reduced. Proper diabetes management can also lower the risk of heart disease and stroke. Taking this medicine regularly, along with a healthy diet and exercise, is essential for leading a normal, healthy life. It is important to continue using the medication as prescribed to protect your future health.
Should you consult a doctor?
It is crucial to seek medical advice before taking Suitglip-M XR 50/500 Tablet TABLET if you have severe diabetes that is difficult to control, experience symptoms like nausea, vomiting, diarrhea, or rapid weight loss, or have conditions such as lactic acidosis or ketoacidosis. Additionally, if you are dehydrated due to reduced fluid intake, severe vomiting, or diarrhea, it is important to consult a doctor before using this medication. Seek immediate medical attention if you have a severe systemic infection, shock, circulation problems, breathing difficulties, or if you are an alcoholic. Moreover, if you are scheduled for upcoming X-rays, it is advisable to inform your healthcare provider.
Before starting Suitglip-M XR 50/500 Tablet TABLET, discuss with your doctor if you have a history of pancreatitis, alcohol dependence, high blood lipid levels, type I diabetes mellitus, upcoming major surgery, fasting, malnutrition, extreme muscle exercises, or a vitamin B12 deficiency. Your doctor can provide personalized guidance based on your individual health circumstances to ensure safe and effective use of this medication.
Side effects of Suitglip-M XR 50/500 Tablet
Side effects may occur while taking Suitglip-M XR 50/500 Tablet, but most of them are not serious and tend to go away as your body gets used to the medication. Some common side effects include decreased appetite, vomiting, upper respiratory tract infection, hypoglycemia (low blood glucose level), abdominal bloating, nausea, and diarrhea. You may also experience drowsiness, dizziness, dry mouth, headache, and skin itching.
If you have any of the following severe side effects, stop taking the medication immediately and consult your doctor: serious allergic reaction (such as hives, swelling of the face, lips, tongue, or throat with difficulty breathing or swallowing), severe blistering of the skin (a sign of an allergic skin reaction called bullous pemphigoid), signs of pancreatitis (severe stomach pain extending to the back with or without nausea and vomiting), and signs of lactic acidosis (including cold hands or feet, dizziness, irregular heartbeat, muscle pain, trouble breathing, and stomach issues).
Other less common side effects that should be addressed with a healthcare provider include hypoglycemia (low blood sugar), nausea, vomiting, flatulence, diarrhea, constipation, stomach pain, loss of appetite, swelling of the hands and legs (edema), upper respiratory infections, stuffy nose, sore throat, joint pain, pain in the arms or legs, and a metallic taste. Remember to consult your doctor if any side effects persist or cause concern.
Safety advice

liver
It is important to note that Suitglip-M XR 50/500 Tablet should be avoided by patients with liver disease as it is likely unsafe for use in such cases. It is advised to consult with your doctor regarding the suitability of this medication if you have any liver issues.

kidney
Suitglip-M XR 50/500 Tablet should be used carefully if you have kidney disease. Your doctor may need to adjust the dose. Avoid using it if you have severe kidney issues. Regularly check your kidney function while on this medication.

alcohol
It is unsafe to drink alcohol while taking Suitglip-M XR 50/500 Tablet. Consulting your doctor is important during pregnancy.

driving
When taking Suitglip-M XR 50/500 Tablet, avoid driving if you experience low or high blood sugar symptoms that may affect your ability to drive safely.

pregnancy
Suitglip-M XR 50/500 Tablet is considered unsafe during pregnancy. Animal studies have shown harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor regarding its use in pregnancy.

breastfeeding
Suitglip-M XR 50/500 Tablet is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.
Age above 75(Geriatrics)
Suitglip-M XR 50/500 Tablet TABLET should be used with caution in elderly patients (aged above 65 years). Therefore, consult your doctor before taking it.
Age below 6 months(Pediatrics)
Suitglip-M XR 50/500 Tablet TABLET is not recommended for use in children and adolescents (aged below 18 years). However, consult your doctor before taking it.
Consumption warning before consuming Suitglip-M XR 50/500 Tablet
Before consuming Suitglip-M XR 50/500 Tablet, it is essential to be aware of certain warnings. This medication is used to manage high blood sugar in type 2 diabetes patients, reducing the risk of complications such as kidney damage and vision problems, and lowering the chances of heart attacks or strokes.
This tablet is usually prescribed alongside a healthy diet and regular exercise regimen. To optimize its effectiveness, it should be taken consistently at the same time each day and preferably with meals to minimize the risk of an upset stomach. One must not discontinue this medication without a doctor's advice. It is crucial to adhere to the recommended lifestyle modifications while on this treatment.
Potential side effects may include diarrhea, nausea, vomiting, headaches, upset stomach, and sore throat. Additionally, there is a risk of low blood sugar levels, especially if taking other diabetes medications concurrently. It is important to be able to recognize and manage symptoms of hypoglycemia.
Certain individuals, such as those with kidney, liver, or heart issues, pancreatic problems, or who consume alcohol significantly, may not be suitable candidates for this medication. Pregnant or nursing women should consult their healthcare provider before using Suitglip-M XR 50/500 Tablet. It is also crucial to inform your doctor about all other medications being taken to avoid potential interactions. Regular monitoring of kidney function and blood sugar levels is necessary during treatment.
What if you forgot to take Suitglip-M XR 50/500 Tablet?
If you forget to take a dose of Suitglip-M XR 50/500 Tablet, you should try to take it as soon as you remember. But if it is nearly time for your next scheduled dose, it's best to just skip the missed dose and continue with your usual dosing schedule. It's important not to take a double dose to make up for the missed one. Following these guidelines will help you maintain the proper dosage routine for your medication.
What happens if you take overdose of Suitglip-M XR 50/500 Tablet?
If you or someone else takes too much Suitglip-M XR 50/500 Tablet Tablet by accident, it's important to seek medical help right away. An overdose can lead to symptoms like feeling very cold or uncomfortable, severe nausea or vomiting, stomach pain, unexplained weight loss, muscle cramps, and fast breathing. Don't hesitate to consult your doctor or go to the nearest hospital if you suspect an overdose.
Related lab tests
For individuals taking Suitglip-M XR 50/500 Tablet, there are several related lab tests that may be relevant to monitor their health. These tests include:
1. Blood Glucose Fasting (FBS): This test measures the level of glucose in the blood after fasting for a certain period of time, usually overnight. It is used to assess overall blood sugar control.
2. Post Prandial Blood Sugar (PPBS): This test measures the level of glucose in the blood after a meal. It helps evaluate how the body processes sugar after eating.
3. HbA1C (Glycated Hemoglobin): This test measures the average blood sugar levels over the past 2-3 months, providing a longer-term view of blood sugar control.
Monitoring these lab tests regularly can help healthcare providers assess the effectiveness of the treatment with Suitglip-M XR 50/500 Tablet and make any necessary adjustments to ensure optimal diabetes management. Other related tests may also be recommended based on individual health needs and medical history.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹98.95
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024